Preeta Tyagi. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Anticarcinogenic Agents/administration & dosageAnticarcinogenic Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useBexaroteneCarboplatin/administration & dosageCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Non-Small-Cell Lung/pathologyCisplatin/administration & dosageFemaleHumansInfusions, IntravenousLung Neoplasms/drug therapyLung Neoplasms/pathologyMaleMiddle AgedPaclitaxel/administration & dosageSurvival AnalysisTetrahydronaphthalenes/administration & dosageTetrahydronaphthalenes/therapeutic useTreatment OutcomeVinblastine/administration & dosageVinblastine/analogs & derivativesVinorelbine
Substances: See more » Anticarcinogenic AgentsTetrahydronaphthalenesVinblastineBexaroteneCarboplatinPaclitaxelCisplatinVinorelbine
Year: 2005 PMID: 16098239 DOI: 10.1016/S1525-7304(11)70385-0
Source DB: PubMed Journal: Clin Lung Cancer ISSN: 1525-7304 Impact factor: 4.785